Nanjing Hicin Pharmaceutical Co Ltd (300584)

Currency in CNY
44.72
+1.82(+4.24%)
Closed·
300584 Scorecard
Full Analysis
Impressive gross profit margins
300584 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
42.4445.35
52 wk Range
15.5446.75
Key Statistics
Bid/Ask
44.72 / 44.73
Prev. Close
42.9
Open
43
Day's Range
42.44-45.35
52 wk Range
15.54-46.75
Volume
21.82M
Average Volume (3m)
17.09M
1-Year Change
161.72%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300584 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Nanjing Hicin Pharmaceutical Co Ltd Company Profile

Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates. The company’s products include landiolol hydrochloride, rivaroxaban, tigecycline, torasemide, cefotiam hydrochloride, and adenosine monophosphate for injection; voglibose tablets, ansoprazole enteric-coated tablets, amlodipine besylate tablets, and glucosamine sulfate effervescent tablets/granules; and raw materials, intermediates, and other products. Its products are used in cardiovascular and cerebrovascular, diuretic, anti-infection, digestive system, immune regulation, hypoglycemic, orthopedics, and other treatment areas. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is headquartered in Nanjing, China.

Employees
548
Market
China

Compare 300584 to Peers and Sector

Metrics to compare
300584
Peers
Sector
Relationship
P/E Ratio
122.9x46.9x−0.5x
PEG Ratio
10.37−1.400.00
Price/Book
5.0x3.1x2.6x
Price / LTM Sales
9.5x5.1x3.3x
Upside (Analyst Target)
-2.7%42.8%
Fair Value Upside
Unlock−6.5%6.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.35%
Dividend Yield
0.22%
Industry Median 1.51%
Annualised payout
0.10
Paid annually
5-Years Growth
-16.74%
Growth Streak

Earnings

Latest Release
Apr 20, 2025
EPS / Forecast
0.13 / --
Revenue / Forecast
142.65M / --
EPS Revisions
Last 90 days

300584 Income Statement

FAQ

What Stock Exchange Does Nanjing Hicin Pharma Trade On?

Nanjing Hicin Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Nanjing Hicin Pharma?

The stock symbol for Nanjing Hicin Pharma is "300584."

What Is the Nanjing Hicin Pharma Market Cap?

As of today, Nanjing Hicin Pharma market cap is 5.37B.

What Is Nanjing Hicin Pharma's Earnings Per Share (TTM)?

The Nanjing Hicin Pharma EPS (TTM) is 0.35.

From a Technical Analysis Perspective, Is 300584 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nanjing Hicin Pharma Stock Split?

Nanjing Hicin Pharma has split 1 times.

How Many Employees Does Nanjing Hicin Pharma Have?

Nanjing Hicin Pharma has 548 employees.

What is the current trading status of Nanjing Hicin Pharma (300584)?

As of 06 Aug 2025, Nanjing Hicin Pharma (300584) is trading at a price of 44.72, with a previous close of 42.90. The stock has fluctuated within a day range of 42.44 to 45.35, while its 52-week range spans from 15.54 to 46.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.